Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment of breast cancer, extends its sincere ...
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
The 2025 respiratory season has reached Greater Cincinnati and is already having an impact on schools and hospitals across ...
according to the Centers for Disease Control and Prevention. Infection spikes also are being seen in Europe and other parts of the world. An infectious disease expert at Baylor College of Medicine ...
according to the latest data from the Centers for Disease Control and Prevention (CDC). Current data from the CDC’s NoroSTAT monitoring system show 495 reported outbreaks during the period from ...
Primary hyperoxaluria is a significant kidney stone disease ... Centers are recognized for having a multidisciplinary team of experts managing a patient’s care. Geneticists, dietitians, nephrologists, ...